Sexual identity and prevalence of alcohol and other drug use among Australians in the general population

Sexual identity and prevalence of alcohol and other drug use among Australians in the general population
复制标题

DOI:
10.1016/j.drugpo.2015.11.005
复制
发表时间:
2016-02-01
影响因子:
4.4
通讯作者:
Degenhardt, Louisa
Degenhardt, Louisa
中科院分区:
医学2区
文献类型:
--
作者:
Roxburgh, Amanda;Lea, Toby;Degenhardt, Louisa

文献摘要

被引文献

相似文献

背景资料:国际研究评估了男女同性恋、双性恋和变性者(LGBTI)和异性恋人群中酒精和其他药物使用流行率的差异,结果显示LGBTI人群中药物使用流行率较高。到目前为止,还没有研究发表调查这些差异在人口水平的男性和女性在澳大利亚。方法:2013年国家药物战略家庭调查是一项多阶段分层人口抽样调查,收集14岁以上澳大利亚人口使用AOD的数据,分析了男同性恋和双性恋(GB)男性和女同性恋/男同性恋和双性恋(LGB)女性与异性恋者之间的差异:(1)一生和过去一年烟草和AOD使用的流行率;(2)开始烟草和AOD使用的年龄;(3)酒精和大麻使用的频率以及AOD治疗史。与异性恋男性(12.4%,2.9%和2.5%)相比,GB男性在过去一年中使用大麻(22.4%),摇头丸(11.8%)和甲基苯丙胺(9.7%)的比例有所上升。LGB妇女还报告说,与异性恋妇女(10.6%和7.1%)相比,过去一年的使用率较高(烟草- 23.7%;大麻- 24.6%)。LGB妇女开始吸烟(15.2岁)和酒精(15.5岁),比异性恋女性早(16.6岁和17.7岁),并且更有可能报告每日饮酒量(OR 3.2,95% CI:2.1,5.1),每周或更频繁地使用大麻(OR 1.7,95% CI:1.1,3.1)。这些发现表明,澳大利亚需要为LGBTI社区提供更具响应性和针对性的AOD伤害减少和治疗服务。令人关切的是,同性恋、双性恋和变性妇女过早开始使用药物的风险增加,并形成有问题的消费模式。需要进一步研究,调查LGB妇女使用AOD的风险和保护因素。(C)2015 Elsevier B. V.版权所有。
Background: International research assessing differences in the prevalence of alcohol and other drug (AOD) use among Lesbian Gay Bisexual and Transgender (LGBTI) and heterosexual populations shows elevated prevalence rates of substance use among LGBTI people. To date no research has been published investigating these differences at a population level among both men and women in Australia.Methods: The 2013 National Drug Strategy Household Survey, a multistage stratified population sample collecting data on AOD use in the Australian population over 14 years of age, was analysed for differences between gay and bisexual (GB) men and lesbian/gay and bisexual (LGB) women and their heterosexual counterparts in: (1) the prevalence of lifetime and past year tobacco and AOD use; (2) age of initiation of tobacco and AOD use; and (3) frequency of alcohol and cannabis use, and history of AOD treatment.Results: There were elevated rates of past year cannabis (22.4%), ecstasy (11.8%) and methamphetamine (9.7%) use among GB men compared to heterosexual men (12.4%, 2.9% and 2.5%). LGB women also reported elevated rates of past year use (tobacco - 23.7%; cannabis - 24.6%) compared to heterosexual women (10.6% and 7.1%). LGB women initiated tobacco (15.2 years) and alcohol (15.5 years) at an earlier age than heterosexual women (16.6 and 17.7 years), and were significantly more likely to report daily alcohol consumption (OR 3.2, 95% CI: 2.1, 5.1), and weekly or more frequent cannabis use (OR 1.7, 95% CI: 1.1, 3.1).Conclusions: These findings are indicative of the need for more responsive and targeted AOD harm reduction and treatment services for LGBTI communities in Australia. Of concern is the elevated risk among LGB women for earlier initiation of substance use, and the development of problematic consumption patterns. Further research, investigating the risk and protective factors for AOD use among LGB women is warranted. (C) 2015 Elsevier B.V. All rights reserved.